In sum, we report that a network of upstream factors genetically linked to PAH converges upon the miR-130/301-PPARγ-LRP8 axis with implications for controlling matrix remodeling and pulmonary vascular disease manifestation. This evidence concerns the gene PPARG and pulmonary arterial hypertension.